Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.990
-0.120 (-2.92%)
At close: Sep 4, 2026, 4:00 PM EDT
4.020
+0.030 (0.75%)
After-hours: Sep 4, 2026, 7:41 PM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $377.74 million as of September 4, 2026. Its market cap has increased by 206.23% in one year.
Market Cap
377.74M
Enterprise Value
240.82M
1-Year Change
206.23%
Ranking
Category
Stock Price
$3.99
ChartMarket Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $377.74M, a decrease of -35.70%. That is a compound annual growth rate of -6.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 377.74M | 332.13% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexeo Therapeutics | 401.19M |
| X4 Pharmaceuticals | 400.55M |
| Larimar Therapeutics | 399.79M |
| EyePoint | 394.85M |
| Opus Genetics | 388.52M |
| Century Therapeutics | 382.07M |
| Agenus | 370.97M |
| Palisade Bio | 364.23M |